HealthStats NSW
HealthStats NSW
HealthStats NSW

Cancer: New cases and cancer-related deaths

Cancer-related deaths, Females, Urogenital
4.5Cancer-related deaths, Males, Urogenital
32.8Cancer-related deaths, Females, Upper gastrointestinal
18.3Cancer-related deaths, Males, Upper gastrointestinal
33.9Cancer-related deaths, Females, Thyroid and other endocrine
0.5Cancer-related deaths, Males, Thyroid and other endocrine
0.8Cancer-related deaths, Females, Skin
2.5Cancer-related deaths, Males, Skin
6.7Cancer-related deaths, Females, Respiratory
22.1Cancer-related deaths, Males, Respiratory
42.5Cancer-related deaths, Females, Neurological
3.3Cancer-related deaths, Males, Neurological
6.3Cancer-related deaths, Females, Lymphohaematopoietic
11.5Cancer-related deaths, Males, Lymphohaematopoietic
22.1Cancer-related deaths, Females, Head and neck
1.8Cancer-related deaths, Males, Head and neck
7Cancer-related deaths, Females, Gynaecological
11.5Cancer-related deaths, Females, Eye
0.3Cancer-related deaths, Males, Eye
0.2Cancer-related deaths, Females, Cancer unknown primary
6.7Cancer-related deaths, Males, Cancer unknown primary
8.1Cancer-related deaths, Females, Breast
18.9Cancer-related deaths, Males, Breast
0.2Cancer-related deaths, Females, Bowel
14.7Cancer-related deaths, Males, Bowel
21.3Cancer-related deaths, Females, Bone and connective tissue
1Cancer-related deaths, Males, Bone and connective tissue
1.3New cases, Males, Urogenital
190.3New cases, Females, Urogenital
14.5New cases, Males, Upper gastrointestinal
55New cases, Females, Upper gastrointestinal
28.2New cases, Males, Thyroid and other endocrine
8.1New cases, Females, Thyroid and other endocrine
21.2New cases, Males, Skin
73.8New cases, Females, Skin
43.9New cases, Males, Respiratory
59.6New cases, Females, Respiratory
36.1New cases, Males, Neurological
8.9New cases, Females, Neurological
5.7New cases, Males, Lymphohaematopoietic
66.4New cases, Females, Lymphohaematopoietic
44.8New cases, Males, Head and neck
22.6New cases, Females, Head and neck
7.2New cases, Females, Gynaecological
40.7New cases, Males, Eye
1.5New cases, Females, Eye
0.8New cases, Males, Cancer unknown primary
12.4New cases, Females, Cancer unknown primary
9.6New cases, Males, Breast
1New cases, Females, Breast
128.1New cases, Males, Bowel
66.2New cases, Females, Bowel
52.4New cases, Males, Bone and connective tissue
4.2New cases, Females, Bone and connective tissue
3.9
  • + Source

    Annual NSW cancer incidence and mortality data from the Cancer Institute NSW. Population estimates based on data from the Australian Bureau of Statistics (SAPHaRI). Centre for Epidemiology and Evidence, NSW Ministry of Health.

  • + Notes

    Primary site of cancer (topography) and cell type (morphology) are coded according to the International Classification of Diseases for Oncology, third edition (ICD-O-3). Hospitals in NSW code disease in ICD-10 AM (Australian modification) and are required to notify the following invasive codes: C00-C76, C80-C96. Notification of basal and squamous cell carcinoma of skin is not required (C44, M805-M811). 

    For the purposes of reporting, only primary invasive cancers are counted and included in statistics. Multiple primary cancers in the same person are counted according to the rules set out by the International Association of Cancer Registries. In this module, mesothelioma, Kaposi's sarcoma, lymphoma and other neoplasms of haematopoietic and reticuloendothelial systems are tabulated as separate entities and not included in the statistics for the organs in which these diseases were diagnosed. 

    This module is based on grouping ICD-O3 topography and morphology codes that are similar to ICD-10 classifications but follow earlier ICD-9 coding used in incidence and mortality reports from 1995. These reporting categories have been used to ensure continuity of trends.

    Rates were age-adjusted using the Australian population as at 30 June 2001. Numbers for the latest year of data include an estimate of the small numbers of deaths that were registered in the subsequent year, data for which were unavailable at the time of production. No number is displayed in the table if the number of cases is <5. 

  • + Data Table
  • + Download
    • Add to My Report
    • Download the indicator content
    • Download the data
    • Download the associated information
    • Download the graph image
  • + Methods
  • + Codes
    • Cancer group codes

      Clinical group

      Cancer type (ICD-O3 codes)

      Skin

       

       

      Lip (C00)

      Melanoma of skin (C44 and M872-M879)

      Kaposi's sarcoma (M914)

      Head and neck

       

       

       

       

       

       

       

       

      Tongue (C01,C02)

      Mouth (C03-C06)

      Salivary gland (C07,C08)

      Oropharyngeal (C09,C10)

      Nasopharyngeal (C11)

      Hypopharyngeal (C12,C13)

      Other oral cavity & pharyngeal (C14)

      Nose, sinuses, etc. (C30,C31)

      Laryngeal (C32)

      Eye

      Eye (C69)

      Upper gastrointestinal

       

       

       

       

       

      Oesophageal (C15)

      Stomach (C16)

      Small intestinal (C17)

      Liver (C22)

      Gallbladder (C23,C24)

      Pancreatic (C25)

      Colorectal

       

      Colon (C18)

      Rectal (C19-C21)

      Respiratory

       

       

      Lung (C33,C34)

      Other thoracic (C37,C38)

      Mesothelioma (M905)

      Bone and connective tissue

       

      Bone (C40,C41)

      Connective tissue, peripheral nerves (C47,C49)

      Breast

      Breast (C50)

      Gynaecological

       

       

       

       

      Cervical (C53)

      Uterine (C54,C55)

      Ovarian (C56,C57.0-C57.7)

      Placental (C58)

      Other female genital (C51,C52,C57.8-C57.9)

      Urogenital

       

       

       

       

      Prostate (C61)

      Testicular (C62)

      Other male genital  (C60,C63)

      Kidney (C64-C66,C68)

      Bladder (C67)

      Neurological

       

      Brain (C71)

      Central nervous system (C70,C72)

      Thyroid and other endocrine

       

      Thyroid (C73)

      Other endocrine gland (C74,C75)

      Lymphohaematopoietic

       

       

       

       

       

       

       

       

       

       

      Hodgkins disease (M965-M966)

      Non-Hodgkins lymphoma (M959,M967-M972,M974)

      Multiple myeloma (M973,M976)

      Acute lymphoblastic leukaemia (M9821)

      Other lymphoid leukaemia (M9820,M9822-M9827,M994)

      Acute myeloid leukaemia (M9861)

      Other myeloid leukaemia (M9860,M9862-8,M987-M988,M9930,M9987)

      Other specified leukaemia (M984,M985,M989-M993)

      Unspecified leukaemia (M980)

      Myelodysplasia (M998)

      Other lymphoid haematopoietic (C42,C77 and M974,M975,M995-M997(excl. M9963))

  • + Related Indicators
  • + Associated Information
    • Key points: Cancer

      • Cancer is Australia's leading cause of disease burden. It accounts for almost one-fifth of years of healthy life lost due to premature death, disease, and injury.

      • In NSW in 2016, there were 44,978 new cases of cancer (55% in males) and 13,944 deaths (57% in males). Over the 20 years between 1997 and 2016, the incidence rate all cancers increased by 4% in males and by 15% in females. Death rates fell by 28% in males and 12% in females over this same 20 year period.

      • In 2016 in NSW the five leading types of new cases of cancer in descending order were:

      • prostate cancer

      • breast cancer

      • melanoma

      • lung cancer

      • colon cancer.

      • However in 2016 in NSW:

      • lung cancer was the leading cause of cancer death

      • colon cancer was the second leading cause of cancer death

      • breast cancer was the third leading cause of cancer death

      • prostate cancer was the fourth leading cause of cancer death

      • pancreatic cancer was the fifth leading cause of cancer death

      • melanoma was the fourteenth leading cause of cancer death.

    • Introduction: Cancer

      Definitions

      Cancer is a diverse group of diseases in which abnormal cells proliferate and spread out of control. Cancer can develop from most types of cells in different parts of the body, each with its own pattern of growth and spread.

      Some cancers are very invasive and invade adjacent organs and spread to other parts of the body (metastasise) quickly, while others may remain in the body for years without showing any clinical symptoms. Benign neoplasms never spread to distant organs.

      Cancers are classified according to the organ in which they originate (primary site). Even when cancers spread to other organs (secondary cancers or metastases) it is usually possible to ascertain the origin of the malignant cells.

      Burden of disease from cancer

      Cancer is a major cause of mortality in Australia and contributes greatly to morbidity and disability. It accounts for 18% of the total burden of disease in Australia (AIHW 2019).

      Risk factors

      Most cancers have a unique set of causal factors, but many share risk factors. These include: smoking (responsible for the majority of preventable cancers); dietary influences; infectious agents; radiation (including ultraviolet radiation); and genetic factors. The most significant risk factor for developing cancer is old age.

      References

      AIHW 2019. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015. Australian Burden of Disease Study series no. 18. Cat. no. BOD 21. Canberra: AIHW. Available at: https://www.aihw.gov.au/reports/burden-of-disease/burden-disease-study-illness-death-2015/contents/table-of-contents

    • Interventions: Cancer

      Some cancers can be prevented though the avoidance of known risk factors. Risk of death from a number of cancers can be reduced by screening, early detection and appropriate and timely diagnosis treatment, and appropriate management and follow-up. 

      The Cancer Institute NSW is part of NSW Health and is NSW's cancer control agency. It was established under the Cancer Institute NSW (2003) Act and aims to lessen the impact of cancer across the State. The Cancer Institute NSW has the latest data and information on: cancer prevention, including quitting smoking, staying active, maintaining a healthy weight, reducing alcohol intake, and minimising sun exposure; cancer screening and early detection programs in NSW including breast, cervical and bowel cancer screening; and cancer treatment and management

      References

      Cancer Institute NSW. NSW Cancer Plan. Lessening the impact of cancers in NSW

    • For more information: Cancer

      Useful websites include:

      Cancer Institute NSW at http://www.cancerinstitute.org.au

      Australian Bureau of Statistics at http://www.abs.gov.au

      Australian Institute of Health and Welfare at http://www.aihw.gov.au

      Healthdirect at http://www.healthdirect.gov.au

      New South Wales Government. Public Health Act 1991 and Public Health Act 2010. Parliamentary Counsel's Office. Available at http://www.legislation.nsw.gov.au

Last Updated At: Tuesday, 2 June 2020